Dr. Vishal Rao Leads Cancer Drug Development and pioneering Health Initiative in Bangalore
Clinical data indicates the formulation shows reduced kidney and gastrointestinal toxicity compared to conventional methods.
Clinical data indicates the formulation shows reduced kidney and gastrointestinal toxicity compared to conventional methods.
Sushma's letter to PM Modi said that the US Food and Drug Administration (FDA) has tested and approved as the first line treatment a new drug called Sacituzumab Govitecanor (Trodelvy). The European Medicines Agency too has approved of it. She said that she is suffering from triple negative metastatic breast cancer which has very limited treatment options but this drug can lend her a new life.
